CITIGROUP RAISED ITS PT FOR BRISTOL-MYERS SQUIBB TO $40 (BMY) Zacks.com ... manufactures and sells pharmaceutical and nutritional products. The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. |
